$PTN They pay their 20-30 or so staff, a total cost of around $10,000,000 each year. Plus research and development, trial cost, marketing expenses for Vyleesi. If Steve says they will not dilute - you bet they will. Unless they get a good upfront payment for Vyleesi, I don't see any other way around that....Steve and Carl should immediately reduce their salary to $0 cash, and 100% stock. THEN and only then would I see that they are fully aligned with shareholders.